Latest News About - Gastroenterology and urology devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, May 25, 2019

3:07:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Richard Rothstein said: "We know from treatment algorithms and treatment in practice that there are major variations in response to various therapeutic drugs," "Other than metformin, there were just a handful of people who had any of the other specific drugs" External link

medpage Thursday, May 23, 2019 6:49:00 PM CEST

David McNally added: “We are taking the necessary steps to ensure a successful launch, following regulatory clearance,” “We have bolstered our global patent position, which now stands at 35 issued and 73 patents pending. Our agreement with Teleflex for ligation instruments will expand the types of procedures our system will be able to perform in the future. We are also proud to have welcomed our new chairman of the board earlier this month, Charles Federico, a prominent medical technology executive who possesses deep experience and a track record of success in strategic planning, corporate governance, and successful commercialization” External link

4-traders Wednesday, May 15, 2019 1:35:00 AM CEST

Diana Blithe says: “It’s really effective and popularit’s all good,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Diana Greene says: “Many women tolerate negative side effects because their sense of the risk of pregnancy is higher or their anticipation of the consequence of a pregnancy is worse,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Diana Blithe says: “There may be as many as 1,000 possible targets,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Victoria Jennings explains: “There’s machine learning going on in the app that helps it adapt to the woman’s cycle,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Victoria Jennings says: “I would love to see some kind of a hormonal test that could accurately predict ovulation far enough in advance for people to be able to rely on it for pregnancy prevention at a cost that they could afford,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Diana Blithe says: “We have a lot of small studies that demonstrate it works and in a similar way to female methods,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Diana Blithe says: “I’m not promising anything in the next five years for men,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Diana Blithe says: “the FDA is going to have a very high bar, I’m sure, when it comes to getting approval for a drug that will be taken by the person who is not at risk of pregnancy,” External link

scientificamerican Thursday, April 25, 2019 3:27:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.